Resultats de la cerca - Edith Dieleman

  • Mostrar 1 - 6 resultats de 6
Refinar resultats
  1. 1
    Impaired survival and long-term neurological problems in benign meningioma

    Impaired survival and long-term neurological problems in benign meningioma per Hanna van Alkemade, Michelle de Leau, Edith Dieleman, J. W. P. F. Kardaun, Rob van Os, W. Peter Vandertop, Wouter R. van Furth, Lukas J.A. Stalpers

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)

    The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial) per Judi van Diessen, Dirk De Ruysscher, Jan‐Jakob Sonke, E. Damen, Karolina Sikorska, Bart Reymen, Wouter van Elmpt, Gunnar Westman, G. Persson, Edith Dieleman, Hedvig Björkestrand, Corinne Faivre‐Finn, J. Belderbos

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab

    Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab per Iris Walraven, Michel M. van den Heuvel, Judi van Diessen, Eva Schaake, Wilma Uyterlinde, Joachim G.J.V. Aerts, Frederieke Koppe, Henk Codrington, Peter W.A. Kunst, Edith Dieleman, Paul van de Vaart, Marcel Verheij, J. Belderbos

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial

    18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial per Saskia A. Cooke, Dirk De Ruysscher, Bart Reymen, Maarten Lambrecht, G. Persson, Corinne Faivre‐Finn, Edith Dieleman, Rolf Lewensohn, Judi N.A. van Diessen, Karolina Sikorska, Ferry Lalezari, Wouter V. Vogel, Wouter van Elmpt, E. Damen, Jan‐Jakob Sonke, J. Belderbos

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675)

    Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675) per J. Belderbos, Dirk K.M. De Ruysscher, Katrien De Jaeger, Friederike Koppe, Maarten Lambrecht, Yolande Lievens, Edith Dieleman, Jaap Jaspers, Jan P. van Meerbeeck, Fred Ubbels, Margriet Kwint, Marianne A. Kuenen, Sabine Deprez, Michiel B. de Ruiter, Willem Boogerd, Karolina Sikorska, Harm van Tinteren, Sanne B. Schagen

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial

    Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial per Martijn H. van der Ree, Edith Dieleman, J. Visser, R. Nils Planken, S. Matthijs Boekholdt, Rianne H A de Bruin-Bon, C. Rasch, Wiert F. Hoeksema, Rianne M A J de Jong, Michiel J. B. Kemme, Jippe C. Balt, Arthur A.M. Wilde, Brian V. Balgobind, Pieter G. Postema

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: